NDRG2 and hepatocellular carcinoma: We therefore analyzed the expression of genes including FXR and NDRG2 in a commercially available cDNA panel derived from liver specimens from healthy individuals and liver specimens from patients with stage I, II, IIIA and IV hepatocellular carcinoma as well as non-malignant liver diseases.